The origin of estrogen receptor alpha-positive and alpha-negative breast cancer.
Affiliation
Breast Biology Group, Division of Cancer Studies, University of Manchester Christie Hospital (NHS) Trust, Manchester, UK.Issue Date
2008
Metadata
Show full item recordCitation
The origin of estrogen receptor alpha-positive and alpha-negative breast cancer. 2008, 617:79-86 Adv. Exp. Med. Biol.Journal
Advances in Experimental Medicine and BiologyPubMed ID
18497032Type
ArticleLanguage
enISSN
0065-2598Related articles
- Expression of estrogen receptors alpha and beta in early steps of human breast carcinogenesis.
- Authors: Roger P, Esslimani-Sahla M, Delfour C, Lazennec G, Rochefort H, Maudelonde T
- Issue date: 2008
- Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
- Authors: Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T
- Issue date: 2009 Sep
- Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
- Authors: Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA
- Issue date: 2008
- P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
- Authors: Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B
- Issue date: 2011 May 16
- Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
- Authors: Ma G, Zhang B, Xu J
- Issue date: 2020 Apr